Clinical Trial: Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Multi-Center, Randomized, Open, Phase II Study to Evaluate Efficacy and Safety in Chemotherapy-induced Neutropenia of Once-per-cycle DA-3031(PEG-G-CSF) and Daily G-CSF in

Brief Summary: This study is to examine which dose of DA-3031(PEG-G-CSF) has similar efficacy and safety compared to daily G-CSF in chemotherapy-induced neutropenia.